Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00512 GRAND PHARMA
RT Nominal up8.700 +0.010 (+0.115%)
Ranking Overview
Buy
Ranking based on 3 research report(s)
Average Ranking 2.00
0
3
0
0
0
Previous Financial Performance
Financial Year 12/2024 EPS 70.49 HKD (cts)
Net Profit 2,468.38 HKD (MIL) DPS 26.00 HKD (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(HKD (MIL))
EPS/
((LPS)(HKD (cts))
DPS
(HKD (cts))
Net Asset Value per Share
(HKD)
Highest
(HKD (MIL))
Lowest
(HKD (MIL))
20252,117.0060.0021.42--2,464.001,913.00
20262,377.0067.0025.41--2,714.002,100.00
20272,853.0080.5029.51--3,084.002,622.00
Profit Estimation
Profit Estimation Profit / (Loss)
(HKD (MIL))
EPS*/
(LPS) (HKD (cts))
DPS *
(HKD (cts))
Broker Ranking Target Price*
(HKD)
Update Date
20252,464.0069.00--CITIC SECBuy13.00 02/09/2025
20252,117.0060.0023.83HUATAI FIN HLDGS HKBuy12.00 21/08/2025
20251,913.0054.0019.00CICCOutperform11.70 23/08/2025
 
20262,714.0076.00--CITIC SEC----02/09/2025
20262,377.0067.0026.81HUATAI FIN HLDGS HK----21/08/2025
20262,100.0059.0024.00CICC----23/08/2025
 
20273,084.0087.00--CITIC SEC----02/09/2025
20272,622.0074.0029.51HUATAI FIN HLDGS HK----21/08/2025
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 22/09/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service